BAGUIO CITY (PIA) — With viral hepatitis a significant public health concern, the Department of Health enjoins everyone to support the government in its disease prevention program.

Interim analyses on track for the first and second half of 2026SOUTH SAN FRANCISCO, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage ...

PHILIPPINE Health Insurance Corporation (PhilHealth) members can avail of benefit packages of up to P24,765 for ...

MANILA – Members of the Philippine Health Insurance Corporation (PhilHealth) can avail of benefit packages of up to PHP24,765 ...

The Philippine Health Insurance Corporation (PhilHealth) urged its members on Monday to avail of free vaccines and benefit ...

Topline data were announced from two phase 3 studies evaluating bepirovirsen for the treatment of chronic hepatitis B.

(Yicai) Jan. 21 -- Chinese innovative pharmaceutical company Kawin Technology plummeted today after withdrawing its ...

New report highlights progress and persistent gaps in global viral hepatitis elimination, underscoring need to expand testing ...

Learn about Hepatitis A, its transmission, symptoms, treatment, and the urgent need for vaccination amidst rising cases in ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today provided key program updates, including new positive data from the ongoing SOLSTICE Phase 2 trial in chronic hepatitis delta (CHD). Participants receiving ...

GSK will be filing for approval of bepirovirsen in hepatitis B to global regulatory authorities based on the Phase III data.

The company said Hevaxin is the only hepatitis E vaccine approved by the Drug Controller General of India (DCGI) and is ...